 | • レポートコード：MRC23Q36057 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の関節内出血治療市場について調査・分析し、世界の関節内出血治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（手術治療、医療治療）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Novartis AG、Pfizer Inc.、Sun Pharmaceuticals Ltd、Merck KGaA、Bayer Healthcare、BioMarin Pharmaceutical, Inc.、Biogen、Chugai Pharmaceutical Co.、Novo Nordisk、Shire Plc.などが含まれています。世界の関節内出血治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、関節内出血治療市場規模を推定する際に考慮しました。本レポートは、関節内出血治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、関節内出血治療に関するビジネス上の意思決定に役立てることを目的としています。 ・関節内出血治療市場の概要 - 関節内出血治療のタイプ別セグメント - 世界の関節内出血治療市場規模：タイプ別分析（手術治療、医療治療） - 関節内出血治療の用途別セグメント - 世界の関節内出血治療市場規模：用途別分析（病院、クリニック、その他） - 世界の関節内出血治療市場規模予測（2018年-2029年） ・関節内出血治療市場の成長トレンド - 関節内出血治療の地域別市場規模（2018年-2029年） - 関節内出血治療市場ダイナミクス - 関節内出血治療の業界動向 - 関節内出血治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：手術治療、医療治療 - 世界の関節内出血治療のタイプ別市場規模（2018年-2023年） - 世界の関節内出血治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、クリニック、その他 - 世界の関節内出血治療の用途別市場規模（2018年-2023年） - 世界の関節内出血治療の用途別市場規模（2024年-2029年） ・関節内出血治療の地域別市場規模 - 北米の関節内出血治療市場規模（2018年-2029年） - アメリカの関節内出血治療市場規模（2018年-2029年） - ヨーロッパの関節内出血治療市場規模（2018年-2029年） - アジア太平洋の関節内出血治療市場規模（2018年-2029年） - 中国の関節内出血治療市場規模（2018年-2029年） - 日本の関節内出血治療市場規模（2018年-2029年） - 韓国の関節内出血治療市場規模（2018年-2029年） - インドの関節内出血治療市場規模（2018年-2029年） - オーストラリアの関節内出血治療市場規模（2018年-2029年） - 中南米の関節内出血治療市場規模（2018年-2029年） - 中東・アフリカの関節内出血治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Novartis AG、Pfizer Inc.、Sun Pharmaceuticals Ltd、Merck KGaA、Bayer Healthcare、BioMarin Pharmaceutical, Inc.、Biogen、Chugai Pharmaceutical Co.、Novo Nordisk、Shire Plc. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Hemarthrosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Hemarthrosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Hemarthrosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Hemarthrosis Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Hemarthrosis Treatment include Novartis AG, Pfizer Inc., Sun Pharmaceuticals Ltd, Merck KGaA, Bayer Healthcare, BioMarin Pharmaceutical, Inc., Biogen, Chugai Pharmaceutical Co. and Novo Nordisk, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hemarthrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemarthrosis Treatment.
The Hemarthrosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hemarthrosis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemarthrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Novartis AG
Pfizer Inc.
Sun Pharmaceuticals Ltd
Merck KGaA
Bayer Healthcare
BioMarin Pharmaceutical, Inc.
Biogen
Chugai Pharmaceutical Co.
Novo Nordisk
Shire Plc.
Segment by Type
Operation Treatment
Medical Treatement
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemarthrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemarthrosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Operation Treatment
1.2.3 Medical Treatement
1.3 Market by Application
1.3.1 Global Hemarthrosis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemarthrosis Treatment Market Perspective (2018-2029)
2.2 Hemarthrosis Treatment Growth Trends by Region
2.2.1 Global Hemarthrosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hemarthrosis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Hemarthrosis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Hemarthrosis Treatment Market Dynamics
2.3.1 Hemarthrosis Treatment Industry Trends
2.3.2 Hemarthrosis Treatment Market Drivers
2.3.3 Hemarthrosis Treatment Market Challenges
2.3.4 Hemarthrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemarthrosis Treatment Players by Revenue
3.1.1 Global Top Hemarthrosis Treatment Players by Revenue (2018-2023)
3.1.2 Global Hemarthrosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Hemarthrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemarthrosis Treatment Revenue
3.4 Global Hemarthrosis Treatment Market Concentration Ratio
3.4.1 Global Hemarthrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemarthrosis Treatment Revenue in 2022
3.5 Hemarthrosis Treatment Key Players Head office and Area Served
3.6 Key Players Hemarthrosis Treatment Product Solution and Service
3.7 Date of Enter into Hemarthrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemarthrosis Treatment Breakdown Data by Type
4.1 Global Hemarthrosis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Hemarthrosis Treatment Forecasted Market Size by Type (2024-2029)
5 Hemarthrosis Treatment Breakdown Data by Application
5.1 Global Hemarthrosis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Hemarthrosis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hemarthrosis Treatment Market Size (2018-2029)
6.2 North America Hemarthrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hemarthrosis Treatment Market Size by Country (2018-2023)
6.4 North America Hemarthrosis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemarthrosis Treatment Market Size (2018-2029)
7.2 Europe Hemarthrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hemarthrosis Treatment Market Size by Country (2018-2023)
7.4 Europe Hemarthrosis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemarthrosis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Hemarthrosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hemarthrosis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Hemarthrosis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemarthrosis Treatment Market Size (2018-2029)
9.2 Latin America Hemarthrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hemarthrosis Treatment Market Size by Country (2018-2023)
9.4 Latin America Hemarthrosis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemarthrosis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Hemarthrosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hemarthrosis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Hemarthrosis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Hemarthrosis Treatment Introduction
11.1.4 Novartis AG Revenue in Hemarthrosis Treatment Business (2018-2023)
11.1.5 Novartis AG Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Detail
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Hemarthrosis Treatment Introduction
11.2.4 Pfizer Inc. Revenue in Hemarthrosis Treatment Business (2018-2023)
11.2.5 Pfizer Inc. Recent Development
11.3 Sun Pharmaceuticals Ltd
11.3.1 Sun Pharmaceuticals Ltd Company Detail
11.3.2 Sun Pharmaceuticals Ltd Business Overview
11.3.3 Sun Pharmaceuticals Ltd Hemarthrosis Treatment Introduction
11.3.4 Sun Pharmaceuticals Ltd Revenue in Hemarthrosis Treatment Business (2018-2023)
11.3.5 Sun Pharmaceuticals Ltd Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Detail
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Hemarthrosis Treatment Introduction
11.4.4 Merck KGaA Revenue in Hemarthrosis Treatment Business (2018-2023)
11.4.5 Merck KGaA Recent Development
11.5 Bayer Healthcare
11.5.1 Bayer Healthcare Company Detail
11.5.2 Bayer Healthcare Business Overview
11.5.3 Bayer Healthcare Hemarthrosis Treatment Introduction
11.5.4 Bayer Healthcare Revenue in Hemarthrosis Treatment Business (2018-2023)
11.5.5 Bayer Healthcare Recent Development
11.6 BioMarin Pharmaceutical, Inc.
11.6.1 BioMarin Pharmaceutical, Inc. Company Detail
11.6.2 BioMarin Pharmaceutical, Inc. Business Overview
11.6.3 BioMarin Pharmaceutical, Inc. Hemarthrosis Treatment Introduction
11.6.4 BioMarin Pharmaceutical, Inc. Revenue in Hemarthrosis Treatment Business (2018-2023)
11.6.5 BioMarin Pharmaceutical, Inc. Recent Development
11.7 Biogen
11.7.1 Biogen Company Detail
11.7.2 Biogen Business Overview
11.7.3 Biogen Hemarthrosis Treatment Introduction
11.7.4 Biogen Revenue in Hemarthrosis Treatment Business (2018-2023)
11.7.5 Biogen Recent Development
11.8 Chugai Pharmaceutical Co.
11.8.1 Chugai Pharmaceutical Co. Company Detail
11.8.2 Chugai Pharmaceutical Co. Business Overview
11.8.3 Chugai Pharmaceutical Co. Hemarthrosis Treatment Introduction
11.8.4 Chugai Pharmaceutical Co. Revenue in Hemarthrosis Treatment Business (2018-2023)
11.8.5 Chugai Pharmaceutical Co. Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Detail
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Hemarthrosis Treatment Introduction
11.9.4 Novo Nordisk Revenue in Hemarthrosis Treatment Business (2018-2023)
11.9.5 Novo Nordisk Recent Development
11.10 Shire Plc.
11.10.1 Shire Plc. Company Detail
11.10.2 Shire Plc. Business Overview
11.10.3 Shire Plc. Hemarthrosis Treatment Introduction
11.10.4 Shire Plc. Revenue in Hemarthrosis Treatment Business (2018-2023)
11.10.5 Shire Plc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details